{"entity":{"type":"insider","cik":"0001883766","url":"/insider/0001883766","json_url":"/insider/0001883766.json","name":"Barnett Eva Renee","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":24,"first":"2022-01-11","last":"2025-04-17","span_basis":"filed_date"},"name_variants":[{"name":"Barnett Eva Renee","source":"filing","n_filings":24,"first_seen":"2022-01-11","last_seen":"2025-04-17"}],"transactions":[{"id":5219196,"accession":"0001764013-25-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-25-000076","line_url":"/filing/0001764013-25-000076#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2993.0,"shares_display":"2,993","price_per_share":14.89,"price_display":"14.89","price_state":"stated","total_value":44565.77,"total_display":"44,565.77","total_whole":"44,566","shares_owned_after":396774.0,"shares_owned_after_display":"396,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-16","filed_date":"2025-04-17","scope":"insider"},{"id":4185937,"accession":"0001764013-25-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-25-000067","line_url":"/filing/0001764013-25-000067","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11063.0,"shares_display":"11,063","price_per_share":12.99,"price_display":"12.99","price_state":"stated","total_value":143708.37,"total_display":"143,708.37","total_whole":"143,708","shares_owned_after":403817.0,"shares_owned_after_display":"403,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-09","filed_date":"2025-04-11","scope":"insider","n_lines":2},{"id":4076365,"accession":"0001764013-25-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-25-000031","line_url":"/filing/0001764013-25-000031#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2814.0,"shares_display":"2,814","price_per_share":20.86,"price_display":"20.86","price_state":"stated","total_value":58700.04,"total_display":"58,700.04","total_whole":"58,700","shares_owned_after":321952.0,"shares_owned_after_display":"321,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":4743883,"accession":"0001764013-25-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-25-000014","line_url":"/filing/0001764013-25-000014","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2298.0,"shares_display":"2,298","price_per_share":23.828024369016536,"price_display":"23.83","price_state":"stated","total_value":54756.8,"total_display":"54,756.80","total_whole":"54,757","shares_owned_after":324875.0,"shares_owned_after_display":"324,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider","n_lines":2},{"id":5177886,"accession":"0001764013-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-25-000004","line_url":"/filing/0001764013-25-000004#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4105.0,"shares_display":"4,105","price_per_share":24.1,"price_display":"24.10","price_state":"stated","total_value":98930.5,"total_display":"98,930.50","total_whole":"98,931","shares_owned_after":327064.0,"shares_owned_after_display":"327,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":3227074,"accession":"0001764013-24-000194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000194","line_url":"/filing/0001764013-24-000194#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4174.0,"shares_display":"4,174","price_per_share":25.45,"price_display":"25.45","price_state":"stated","total_value":106228.3,"total_display":"106,228.30","total_whole":"106,228","shares_owned_after":331169.0,"shares_owned_after_display":"331,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2261045,"accession":"0001764013-24-000171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000171","line_url":"/filing/0001764013-24-000171#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3271.0,"shares_display":"3,271","price_per_share":28.79,"price_display":"28.79","price_state":"stated","total_value":94172.09,"total_display":"94,172.09","total_whole":"94,172","shares_owned_after":335343.0,"shares_owned_after_display":"335,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2707996,"accession":"0001764013-24-000166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000166","line_url":"/filing/0001764013-24-000166#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5162.0,"shares_display":"5,162","price_per_share":29.56,"price_display":"29.56","price_state":"stated","total_value":152588.72,"total_display":"152,588.72","total_whole":"152,589","shares_owned_after":338614.0,"shares_owned_after_display":"338,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-09","filed_date":"2024-10-11","scope":"insider"},{"id":2261044,"accession":"0001764013-24-000158","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000158","line_url":"/filing/0001764013-24-000158","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3768.0,"shares_display":"3,768","price_per_share":31.858980891719746,"price_display":"31.86","price_state":"stated","total_value":120044.64,"total_display":"120,044.64","total_whole":"120,045","shares_owned_after":343925.0,"shares_owned_after_display":"343,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider","n_lines":2},{"id":2972268,"accession":"0001764013-24-000135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000135","line_url":"/filing/0001764013-24-000135","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3123.0,"shares_display":"3,123","price_per_share":29.69361511367275,"price_display":"29.69","price_state":"stated","total_value":92733.16,"total_display":"92,733.16","total_whole":"92,733","shares_owned_after":347728.0,"shares_owned_after_display":"347,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider","n_lines":2},{"id":2925377,"accession":"0001764013-24-000127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000127","line_url":"/filing/0001764013-24-000127#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4747.0,"shares_display":"4,747","price_per_share":28.06,"price_display":"28.06","price_state":"stated","total_value":133200.82,"total_display":"133,200.82","total_whole":"133,201","shares_owned_after":350667.0,"shares_owned_after_display":"350,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-10","scope":"insider"},{"id":2616386,"accession":"0001764013-24-000099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000099","line_url":"/filing/0001764013-24-000099#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4042.0,"shares_display":"4,042","price_per_share":29.65,"price_display":"29.65","price_state":"stated","total_value":119845.3,"total_display":"119,845.30","total_whole":"119,845","shares_owned_after":355414.0,"shares_owned_after_display":"355,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-24","scope":"insider"},{"id":2050426,"accession":"0001764013-24-000079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000079","line_url":"/filing/0001764013-24-000079","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12253.0,"shares_display":"12,253","price_per_share":29.058088631355588,"price_display":"29.06","price_state":"stated","total_value":356048.76,"total_display":"356,048.76","total_whole":"356,049","shares_owned_after":362230.0,"shares_owned_after_display":"362,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-17","filed_date":"2024-04-19","scope":"insider","n_lines":2},{"id":3063443,"accession":"0001764013-24-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000073","line_url":"/filing/0001764013-24-000073#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3689.0,"shares_display":"3,689","price_per_share":31.18,"price_display":"31.18","price_state":"stated","total_value":115023.02,"total_display":"115,023.02","total_whole":"115,023","shares_owned_after":371709.0,"shares_owned_after_display":"371,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-10","scope":"insider"},{"id":2196200,"accession":"0001764013-24-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000041","line_url":"/filing/0001764013-24-000041#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2930.0,"shares_display":"2,930","price_per_share":36.15,"price_display":"36.15","price_state":"stated","total_value":105919.5,"total_display":"105,919.50","total_whole":"105,920","shares_owned_after":320420.0,"shares_owned_after_display":"320,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-22","filed_date":"2024-02-23","scope":"insider"},{"id":2196198,"accession":"0001764013-24-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000010","line_url":"/filing/0001764013-24-000010","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3515.0,"shares_display":"3,515","price_per_share":41.82744238975818,"price_display":"41.83","price_state":"stated","total_value":147023.46,"total_display":"147,023.46","total_whole":"147,023","shares_owned_after":324184.0,"shares_owned_after_display":"324,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-12","scope":"insider","n_lines":2},{"id":7984703,"accession":"0001764013-23-000144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000144","line_url":"/filing/0001764013-23-000144","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4055.0,"shares_display":"4,055","price_per_share":32.77924290998767,"price_display":"32.78","price_state":"stated","total_value":132919.83,"total_display":"132,919.83","total_whole":"132,920","shares_owned_after":327019.0,"shares_owned_after_display":"327,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-24","scope":"insider","n_lines":2},{"id":8489840,"accession":"0001764013-23-000120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000120","line_url":"/filing/0001764013-23-000120#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4557.0,"shares_display":"4,557","price_per_share":36.92,"price_display":"36.92","price_state":"stated","total_value":168244.44,"total_display":"168,244.44","total_whole":"168,244","shares_owned_after":330920.0,"shares_owned_after_display":"330,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-10","filed_date":"2023-10-11","scope":"insider"},{"id":8212368,"accession":"0001764013-23-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000103","line_url":"/filing/0001764013-23-000103","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14386.0,"shares_display":"14,386","price_per_share":20.300041012095093,"price_display":"20.30","price_state":"stated","total_value":292036.39,"total_display":"292,036.39","total_whole":"292,036","shares_owned_after":335478.0,"shares_owned_after_display":"335,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-25","scope":"insider","n_lines":2},{"id":7936927,"accession":"0001764013-23-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000080","line_url":"/filing/0001764013-23-000080#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2725.0,"shares_display":"2,725","price_per_share":24.94,"price_display":"24.94","price_state":"stated","total_value":67961.5,"total_display":"67,961.50","total_whole":"67,962","shares_owned_after":349863.0,"shares_owned_after_display":"349,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-20","scope":"insider"},{"id":8453786,"accession":"0001764013-23-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000053","line_url":"/filing/0001764013-23-000053#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3423.0,"shares_display":"3,423","price_per_share":15.27,"price_display":"15.27","price_state":"stated","total_value":52269.21,"total_display":"52,269.21","total_whole":"52,269","shares_owned_after":352588.0,"shares_owned_after_display":"352,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-19","scope":"insider"},{"id":8379415,"accession":"0001764013-23-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000008","line_url":"/filing/0001764013-23-000008","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4510.0,"shares_display":"4,510","price_per_share":16.74609756097561,"price_display":"16.75","price_state":"stated","total_value":75524.9,"total_display":"75,524.90","total_whole":"75,525","shares_owned_after":268347.0,"shares_owned_after_display":"268,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-13","scope":"insider","n_lines":2},{"id":6794138,"accession":"0001764013-22-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000128","line_url":"/filing/0001764013-22-000128#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":9.44,"price_display":"9.44","price_state":"stated","total_value":118000.0,"total_display":"118,000.00","total_whole":"118,000","shares_owned_after":272857.0,"shares_owned_after_display":"272,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-13","scope":"insider"},{"id":6707507,"accession":"0001764013-22-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000011","line_url":"/filing/0001764013-22-000011#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001883766","owner_name":"Barnett Eva Renee","owner_display_name":"Barnett Eva Renee","owner_url":"/insider/0001883766","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29959.0,"shares_display":"29,959","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":217202.75,"total_display":"217,202.75","total_whole":"217,203","shares_owned_after":172541.0,"shares_owned_after_display":"172,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":33,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Officer (Chief Financial Officer)","n_filings":24,"first_seen":"2022-01-11","last_seen":"2025-04-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001883766","retrieved_at":"2026-08-27T07:24:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}